Advances in cancer immunotherapy

Immunol Today. 1999 Feb;20(2):63-5. doi: 10.1016/s0167-5699(98)01388-7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use
  • Antibody-Dependent Cell Cytotoxicity
  • Antigens, Neoplasm / immunology
  • Chimera
  • Clinical Trials as Topic
  • Cytokines / genetics
  • DNA, Complementary / genetics
  • Dendritic Cells / immunology
  • Dendritic Cells / transplantation
  • Dogs
  • Genetic Therapy
  • Graft vs Tumor Effect
  • Humans
  • Immunoconjugates / therapeutic use
  • Immunotherapy / methods
  • Immunotherapy / trends*
  • Immunotherapy, Adoptive
  • Leukemia / therapy
  • Lymphocyte Activation
  • Lymphocyte Transfusion
  • Neoplasms / therapy*
  • Salvage Therapy
  • T-Lymphocytes, Cytotoxic / immunology

Substances

  • Antibodies, Monoclonal
  • Antigens, Neoplasm
  • Cytokines
  • DNA, Complementary
  • Immunoconjugates